Tumor necrosis factor α is toxic to embryonic mesencephalic dopamine neurons

Experimental Neurology

Volumn 169, Issue 2, 2001, Pages 219-230

  McGuire, Susan O ^a   Ling, Zao Dung ^a   Lipton, Jack W ^a   Sortwell, Caryl E ^a   Collier, Timothy J ^a   Carvey, Paul M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell death; Cytokine; Dopamine neuron; Mesencephalon; Neurodegeneration; Oxidative stress; Parkinson's disease; Rat; Tumor necrosis factor; Tumor necrosis factor receptors

Indexed keywords

LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ASSAY; GENE EXPRESSION; GLIA CELL; IMMUNOREACTIVITY; MESENCEPHALON; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0034982202     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7688     Document Type: Article

References (97)

1. Parkinson's disease: Pathophysiology
2. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
3. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging
4. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury
5. TNF protects hippocampal neurons against amyloid B-peptide toxicity: Involvement of NFkB and attenuation of peroxide and calcium accumulation
6. TNFα and IFNγmediated signal transduction pathways: Effects on glial cell gene expression and function
7. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon
8. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
9. Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients
10. Free radical activity of melanins and related substances: Biochemical and pathobiochemical aspects
11. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia
12. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neruons
13. 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat
14. Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system
15. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
16. Ceramide induces apoptosis in cultured mesencephalic neurons
17. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
18. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
19. Free-radical toxicity and antioxidant medication in Parkinson's disease
20. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism
21. Programmed cell death in neurons: Focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons
22. Experimental brain injury induces expression of tumor necrosis factor-α mRNA
23. Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS
24. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha
25. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level
26. TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis
27. Expression of tumor necrosis factor alpha in the developing nervous system
28. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
29. Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: Early events in tumor necrosis factor-induced cytotoxicity
30. Ceramide: An intracellular signal for apoptosis
31. Astrocytes express regional heterogeneity after lipopolysaccharide induction of the immune-reactive phenotype
32. Expression of calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution and distribution in Parkinson's disease
33. Does oxidative stress participate in nerve cell death in Parkinson's disease
34. Iron metabolism and Parkinson's disease
35. Neuronal vulnerability in Parkinson's disease
36. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
37. Nuclear translocation of NF-kB is increased in dopaminergic neurons of patients with Parkinson disease
38. FceRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
39. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-1,4-phenyl-1,2,3,6-tetrahydropyridine
40. Developmental cell death in dopaminergic neurons of the substantia nigra of mice
41. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro
42. Oxidative stress and the pathogenesis of Parkinson's disease
43. Understanding cell death in Parkinson's disease
44. Oxidative stress in Parkinson's disease and other neurodegenerative disorders
45. Oxidative mechanisms in nigral cell death in Parkinson's disease
46. Identification and characterization of receptors for tumor necrosis factor-α in the brain
47. Early neuronal expression of tumor necrosis factor a after experimental brain injury contributes to neurological impairment
48. Signal transduction through the sphingomyelin pathway
49. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
50. Cytotoxic mechanism of tumor necrosis factor α
51. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
52. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
53. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures
54. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
55. Stimulation of different phospholipase A2 isoforms by TNF-alpha and IL-1beta in adult rat ventricular myocytes
56. Tumor necrosis factor-α in ischemic neurons
57. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death
58. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: Evidence for a cytoprotective response
59. Cellular signaling roles of TGF beta. TNF alpha and beta APP in brain injury responses and Alzheimer's disease
60. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration
61. Iron, free radicals, and oxidative injury
62. Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes and glial precursors in vitro
63. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue
64. Tumor necrosis factor-alpha increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
65. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signaling
66. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice
67. An introduction to the free radical hypothesis in Parkinson's disease
68. Attempts to obtain neuroprotection in Parkinson's disease
69. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra
70. Oxidative stress and Parkinson's disease
71. Tumor necrosis factor-α: A neuromodulator in the CNS
72. Up-regulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury
73. Experimental developments in movement disorders: Update on proposed free radical mechanisms
74. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease
75. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: Regulation by Th1 cytokines
76. Cytokines in neurodegeneration and repair
77. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
78. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
79. Inhibition of tumor necrosis factor alpha activity in rat brain is associated with cerebroprotection after closed head injury
80. Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant
81. The TNF receptor 2 signal transducers TRAF2 and c-IAP1 are components of the TNF receptor 1 signaling complex
82. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: Implications for Parkinson's disease
83. A study on tumor necrosis factor, tumor necrosis factor receptors, and nitric oxide in human fetal glial cultures
84. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in the adult rat: Time-course, distribution, and morphology of cell death
85. Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
86. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA
87. The two different receptors for tumor necrosis factor mediate distinct cellular responses
88. Two TNF receptors
89. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor
90. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
91. Two tumor necrosis factor receptors: Structure and functions
92. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide
93. A new concept in neurodegeneration: TNFa is a silencer of survival signals
94. Tumor necrosis factor α attenuates hypoxic/hypoglycaemic damage in organotypic hippocampal cultures
95. Tumor necrosis factor-α specific binding sites in rodent brain and pituitary gland
96. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K
97. Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: Ontogenic inflammation